93 related articles for article (PubMed ID: 21563035)
1. Urine concentrations of repetitive doses of inhaled salbutamol.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Int J Sports Med; 2011 Aug; 32(8):574-9. PubMed ID: 21563035
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
[TBL] [Abstract][Full Text] [Related]
3. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
4. Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes.
Pillard F; Lavit M; Cances VL; Rami J; Houin G; Didier A; Rivière D
Respir Res; 2015 Dec; 16():155. PubMed ID: 26704899
[TBL] [Abstract][Full Text] [Related]
5. Blood and urinary concentrations of salbutamol in asthmatic subjects.
Elers J; Pedersen L; Henninge J; Lund TK; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2010 Feb; 42(2):244-9. PubMed ID: 19927035
[TBL] [Abstract][Full Text] [Related]
6. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
[TBL] [Abstract][Full Text] [Related]
7. Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of use.
Pichon A; Venisse N; Krupka E; Pérault-Pochat MC; Denjean A
Int J Sports Med; 2006 Mar; 27(3):187-92. PubMed ID: 16541373
[TBL] [Abstract][Full Text] [Related]
8. Urine and serum concentrations of inhaled and oral terbutaline.
Elers J; Hostrup M; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Int J Sports Med; 2012 Dec; 33(12):1026-33. PubMed ID: 22782385
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salbutamol and doping control: effects of dose on urine concentrations.
Sporer BC; Sheel AW; Taunton J; Rupert JL; McKenzie DC
Clin J Sport Med; 2008 May; 18(3):282-5. PubMed ID: 18469572
[TBL] [Abstract][Full Text] [Related]
10. Impact of ethnicity, gender, and dehydration on the urinary excretion of inhaled salbutamol with respect to doping control.
Dickinson J; Hu J; Chester N; Loosemore M; Whyte G
Clin J Sport Med; 2014 Nov; 24(6):482-9. PubMed ID: 24518370
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
[TBL] [Abstract][Full Text] [Related]
12. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
14. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control.
Ventura R; Segura J; Bergés R; Fitch KD; Morton AR; Berruezo S; Jiménez C
Ther Drug Monit; 2000 Jun; 22(3):277-82. PubMed ID: 10850394
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysis.
Krogh N; Backer V; Rzeppa S; Hemmersbach P; Hostrup M
Drug Test Anal; 2016 Oct; 8(10):1056-1064. PubMed ID: 26990656
[TBL] [Abstract][Full Text] [Related]
16. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
Watanabe N; Makino S; Kihara N; Fukuda T
Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
[TBL] [Abstract][Full Text] [Related]
17. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
[TBL] [Abstract][Full Text] [Related]
18. The enigma of inhaled salbutamol and sport: unresolved after 45 years.
Fitch KD
Drug Test Anal; 2017 Jul; 9(7):977-982. PubMed ID: 28294577
[TBL] [Abstract][Full Text] [Related]
19. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes.
Hostrup M; Kalsen A; Auchenberg M; Rzeppa S; Hemmersbach P; Bangsbo J; Backer V
Drug Test Anal; 2014 Jun; 6(6):528-32. PubMed ID: 24166762
[TBL] [Abstract][Full Text] [Related]
20. Terbutaline: level the playing field for inhaled β
Jacobson GA; Hostrup M
Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]